Faculty of Dentistry, Jordan University of Science and Technology, Irbid, Jordan.
Faculty of Dentistry, McGill University, Montreal, QC, Canada.
Oral Maxillofac Surg. 2022 Dec;26(4):663-672. doi: 10.1007/s10006-021-01029-8. Epub 2022 Jan 22.
Postoperative pain management impacts patients' quality of life and morbidity. Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen are widely used for this following a 3-doses-per-day regime. However, pain and inflammation follow a circadian rhythm, and animal models assessing the scheduling of NSAID administration (e.g., chronotherapy) have shown that while their use during the active phase of the day enhances postoperative recovery, their administration during the resting phase could have detrimental effects. This observation has led us to hypothesize that night administration of NSAID might be unnecessary in post-surgical scenarios. Therefore, a randomized clinical trial was conducted to test this hypothesis in surgical third molar extractions.
Seventy (18-35 years) healthy participants requiring surgical removal of impacted lower third molars were recruited and randomized into a double-blind placebo-controlled study. For three days postoperatively, the treatment group (n = 33) received ibuprofen (400 mg) at 8 AM, 1 PM, and a placebo at 8 PM, while the control group (n = 37) received ibuprofen (400 mg) at 8 AM, 1 PM, and 8 PM. Pain severity was assessed by visual analog scale (VAS) and healing indicators including facial swelling, mouth opening, and C-reactive protein blood levels were also measured.
Pain VAS measures showed a circadian variation peaking at night. Also, no significant differences were observed between the two groups of the study in terms of postoperative pain scores (estimate: 0.50, 95% CI = [- 0.38, 1.39]) or any other healing indicator.
Postoperative pain follows a circadian rhythm. Moreover, night administration of ibuprofen might not provide any significant benefits in terms of pain management and control of inflammation, and two doses during the day only could be sufficient for pain management after surgical interventions.
Even though this study cannot rule out the possibility that a reduced regime is different than a standard regime, nocturnal doses of ibuprofen seem to have no clinical significance in the short term, and the results of this study provide evidence in favor of reducing ibuprofen administration from three doses to two doses only after third molar surgery.
术后疼痛管理会影响患者的生活质量和发病率。布洛芬等非甾体抗炎药(NSAIDs)广泛用于每天三次的治疗方案。然而,疼痛和炎症遵循昼夜节律,动物模型评估 NSAID 给药时间安排(例如,时间治疗学)表明,虽然在白天活动期使用可促进术后恢复,但在休息期使用可能会产生不利影响。这一观察结果促使我们假设,在手术后的情况下,夜间使用 NSAID 可能是不必要的。因此,进行了一项随机临床试验,以测试这种假设在第三磨牙外科拔牙中的效果。
招募了 70 名(18-35 岁)需要手术切除下颌阻生第三磨牙的健康参与者,并将他们随机分为双盲安慰剂对照研究。术后三天内,治疗组(n=33)在上午 8 点、下午 1 点和晚上 8 点接受布洛芬(400mg)治疗,而对照组(n=37)在上午 8 点、下午 1 点和晚上 8 点接受布洛芬(400mg)治疗。通过视觉模拟评分(VAS)评估疼痛严重程度,还测量了包括面部肿胀、张口度和 C 反应蛋白血水平在内的愈合指标。
疼痛 VAS 测量值显示出夜间高峰的昼夜变化。此外,在术后疼痛评分(估计值:0.50,95%CI=-0.38,1.39)或任何其他愈合指标方面,两组研究之间没有观察到显著差异。
术后疼痛遵循昼夜节律。此外,夜间使用布洛芬在疼痛管理和炎症控制方面可能没有显著益处,仅在白天使用两剂可能足以管理手术后的疼痛。
尽管这项研究不能排除减少剂量与标准剂量不同的可能性,但短期内夜间服用布洛芬似乎没有临床意义,这项研究的结果提供了证据,支持在第三磨牙手术后将布洛芬的给药剂量从三剂减少到两剂。